Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00014755
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
2001-04-10
Brief Title:
Phase I Pilot Study of Total-Body Irradiation Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngeneic or Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Sclerosis
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Office of Rare Diseases ORD
Organization Data
Organization:
Office of Rare Diseases ORD
Class:
NIH
Study ID:
19915796
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Fred Hutchinson Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None